Sanofi Bags EU Approvals But Fumes At Regulator
Green Lights For Nexviadyme And Xenpozyme
Although Nexviadyme has been approved, the French group is still unhappy about the EMA's view that the Pompe disease therapy should not be classified as a new active substance.
